Reference | Number of subjects | Age/gender matched? | Age | Abs./Rel. FA Conc. | Differences reported (ASD versus control) | Â | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ASD | Control |  |  |  | n-6 | n-3 | AA | DHA | EPA | AA/DHA | AA/EPA | Other |
Vancassel et al. 2001 [36] | 15 | 18a | N/N | ASD: 3-17 DD: 1-19 | Relative | N.S. | ↓ | N.S. | ↓ |  |  |  | ↓ n-3/n-6 |
Meguid et al. 2008 [37] | 30 | 30 | Y/Y | 3-11 | Absolute |  |  | ↓ | ↓ |  | ↑ |  | ↓ linolenic and linoleic acids |
Pastural et al. 2009[38] | 15 | 11b | N/N | ASD: 8.7 ±3.9 DD: 7.9 ±2.9 | Relative |  |  | ↑ | ↑ | ↑ |  |  |  |
Bell et al. 2010 [15] | 45 | 45 | Y/Y | ASD: 7.5 ±3.5 DD: 7.5 ±3.6 | Relative | N.S. | N.S. | N.S. | N.S. | N.S. |  | ↑ | ↓ ALA |
Bell et al. 2010 [15] | 38 | 38a | Y/Y | ASD: 7.5 ±3.5 DD: 6.0 ±3.3 | Relative | ↓ | N.S. | N.S. | N.S. | N.S. |  | N.S. |  |
El-Ansary et al. 2011 [13] | 26 | 26 | Y/Y | ASD: 4-12 DD: 4-11 | Absolute |  |  | ↓ | ↓ | N.S. |  |  |  |
Brigandi et al. 2015 [14] | 121 | 110 | N/N | 3-17 | Relative | ↓ | ↓ | ↓ | ↓ | N.S. |  |  |  |
Yui et al. 2016 [24] | 30 | 20 | Y/Y | ASD: 13.6 ±4.3 DD: 13.2 ±5.4 | Absolute |  |  | ↓ | N.S. | ↑ | ↓ | ↓ |  |
Jory et al. 2016 [39] | 11 | 15 | Y/N | ASD: 3.1 ±0.8 DD: 3.9 ±1.1 | Relative |  |  | ↓ | ↓ | ↓ | N.S. | N.S. | ↓ n-3/n-6 and linoleic acid |
Parletta et al. 2016 [16] | 85 | 79 | N/Y | ASD: 5.3 ±2.1 DD: 8.3 ±2.5 | Relative |  |  | ↓ | ↓ | ↓ |  | ↑ | ↓ n-3/n-6 |